BDTX

Black Diamond Therapeutics (BDTX)

About Black Diamond Therapeutics (BDTX)

Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Details

Daily high

$3.65

Daily low

$3.34

Price at open

$3.55

52 Week High

$7.66

52 Week Low

$1.62

Market cap

200.6M

Dividend yield

0.00%

Volume

3,379

Avg. volume

2.5M

P/E ratio

-2.30

Black Diamond Therapeutics News